Achieve Life Sciences, Inc. (NASDAQ:ACHV) has 81 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Franklin Resources Inc | 31 Mar, 2026 | 4,369,193 | 0 | 0.00% | $12,845,427.00 |
| Propel Bio Management, LLC | 31 Mar, 2026 | 3,786,425 | 0 | 0.00% | $11,368,992.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,204,714 | 2,204,714 | 0.00% | $6,481,859.00 |
| Simplify Asset Management Inc. | 31 Mar, 2026 | 1,184,512 | 0 | 0.00% | $3,482,465.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 1,077,338 | -281,778 | -20.73% | $3,167,374.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 1,019,281 | 0 | 0.00% | $2,996,686.00 |
| LPL Financial LLC | 31 Mar, 2026 | 728,448 | 95,300 | 15.05% | $2,141,637.00 |
| Nantahala Capital Management, LLC | 31 Mar, 2026 | 648,885 | 0 | 0.00% | $1,907,722.00 |
| Raymond James Financial Inc | 31 Mar, 2026 | 641,925 | 42,246 | 7.04% | $1,887,259.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 622,785 | 23,174 | 3.86% | $1,831,935.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 588,551 | -160,065 | -21.38% | $1,730,340.00 |
| KVP Capital Advisors, LP | 31 Mar, 2026 | 462,355 | 0 | 0.00% | $1,359,324.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 439,360 | 20,227 | 4.83% | $1,291,718.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 383,683 | -112,667 | -22.70% | $1,128,028.00 |
| UBS Group AG | 31 Mar, 2026 | 326,270 | 41,041 | 14.39% | $959,234.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 316,177 | 316,177 | 0.00% | $929,560.00 |
| State Street Corp | 31 Mar, 2026 | 254,457 | 20,200 | 8.62% | $748,104.00 |
| Northern Trust Corp | 31 Mar, 2026 | 224,742 | -5,137 | -2.23% | $660,741.00 |
| Shay Capital LLC | 31 Mar, 2026 | 205,114 | -29,823 | -12.69% | $603,035.00 |
| 683 Capital Management, LLC | 31 Mar, 2026 | 200,000 | -14,897 | -6.93% | $588,000.00 |